Tag: Cantor Fitzgerald
Why CRISPR is Becoming a Standout Winner
CRISPR Therapeutics could be a standout winner this year, we said on April 13.
We also noted, “Cantor Fitzgerald initiated coverage with an outperform rating,...
CRISPR Therapeutics Could be a Standout Winner this Year
Gene editing stocks, like CRISPR Therapeutics (CRSP), are on the. move.
In fact, CRSP is up about 15% on the day on a volume spike...
Pay Close Attention to Anavex Life Sciences
Keep an eye on Anavex Life Sciences (AVXL).
Over the last few months, the stock exploded from a low of about $4 to 30. While...
This is Why Cassava Sciences (SAVA) Could Explode — Again
Cassava Sciences (SAVA) is soaring again.
After pulling back to strong support around $91, the stock is back to $108 thanks to new price targets,...
Popular Post
